Organ-on-a-chip

#Drug development #Drug discovery #eBook #Emulate #Organ-on-a-chip

eBook: An introduction to organ-on-a-chip technology

Download Emulate’s Introduction to Organ-on-a-Chip Technology eBook to learn about: What Organ-Chips are, how they work, and why they are transforming the way drugs are discovered and developed How Organ-Chips overcome the main challenges of conventional in vivo and in vitro models The wide variety of insights… Read More

#News

Brussels, Belgium
#Biology #Events #Genomics #High Throughput #In vitro #Organ-on-a-chip #Organoids #SLAS #SLAS Europe

SLAS Europe 2023 reveals details of Biology Unveiled track

SLAS Europe has revealed details of the Biology Unveiled track at the upcoming meeting in Brussels, Belgium on May 23-26. The other three tracks are Frontiers in Technology, Shaping the Future of Therapeutics and Bio-Entrepreneurship in Europe. The Biology Unveiled track will feature scientific… Read More

#News

Organ on a chip
#CN Bio #Drug development #Drug screening #In vivo #Organ-on-a-chip #Organoids #SLAS

Organ-on-a-chip models in drug development

This paid-for advertorial by CN Bio appeared in DDW Volume 24 – Issue 2, Spring 2023 Despite advancements, the drug development process remains inefficient. Even with rigorous optimisation and validation, we face a 90% failure rate by the clinical phase1. Existing in vivo and in vitro models aren’t up to… Read More

#Exclusive Content

Cancer cell
#Bioprinting #Cancer research #Oncology #Organ-on-a-chip #Organoids #Precision medicine #Whitepaper

New whitepaper on trends in precision medicine: Cancer

Precision medicine uses information about an individual’s genes, proteins, and environment to prevent, diagnose, and treat diseases, including cancer. Differences in DNA, RNA, and protein can be identified in individual tissue samples, and even in individual cells. The massive data sets generated from this research have driven advances in data… Read More

#News

Organ-on-a-chip
#Bioavailability #CN Bio #Collaboration #FDA #In vitro #Organ-on-a-chip

FDA expands organ-on-a-chip research collaboration

The US Food and Drug Administration (FDA) and CN Bio have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ microphysiological systems (MPS) using the PhysioMimix Multi-organ System.   The system will initially be investigated for improving the preclinical estimation of human drug… Read More

#News

#3D cell culture #Automated workflows #Cell Science #Drug discovery #Organ-on-a-chip #Organoids #Synthetic biology

What an innovation centre means for 3D biology

DDW Editor Reece Armstrong learns about Molecular Devices’ Organoid Innovation Centre (OIC) and how the company is aiming to advance research into 3D biology and organoids.  In April 2021, life sciences solutions provider Molecular Devices launched its Organoid Innovation Centre (OIC), an initiative designed to help scientists leverage the potential of 3D… Read More

#Exclusive Content

#Drug development #Microfluidics #Organ-on-a-chip #Tissue chips

Using microfluidics in drug discovery

Download this 24-page DDW eBook, sponsored by Emulate, to learn about: How microfluidics is fuelling innovation in drug discovery A detailed look at the organ-on-a-chip sector How human tissue chips are helping advance our understanding of biology Download now. Read More

#DDW eBooks #Intelligence

Organ-on-a-chip
#Biopharma #Microfluidics #Organ-on-a-chip

eBook: Using microfluidics in drug discovery

This 24-page DDW eBook, sponsored by Emulate Bio, contains exclusive insight from industry experts on: How microfluidics is fuelling innovation in drug discovery A detailed look at the organ-on-a-chip sector How human tissue chips are helping advance our understanding of biology This guide is free of charge and you can… Read More

#News

#Business #Organ-on-a-chip

CN Bio expand contract services for organ-on-a-chip tech  

Organ-on-a-chip Company (OOC) CN Bio has expanded its contract research services with the opening of new laboratory facilities at Cambridge Science Park, in the UK. The company has double its laboratory space in response to the increasing demand for OOC services as seen throughout drug discovery and development programmes. Read More

#News

#Business #Organ-on-a-chip

CN Bio appoints Chief Business Officer to drive strategy

Organ-on-a-chip Company (OOC) CN Bio has appointed a new Chief Business Officer as part of its commercial business strategy. The company has appointed Dr Paul Brooks to the role, who will be responsible for leading the expansion of its global commercial organisation. Dr Brooks has over 25 years of experience… Read More

#News

#Biology #Drug development #Infectious diseases #MPS technology #Novel therapeutics #Organ-on-a-chip #Toxicology

Hype or hope – microphysiological systems?

Listen to this article on the DDW Podcast: Dr Tomasz Kostrzewski, Director of Biology at CN Bio Innovations, examines MPS in drug discovery as part of a preclinical toolbox.  Drug development remains slow and costly for the pharmaceutical industry, driven by the financial impact of late-stage failures of drug candidates1. Although… Read More

#Exclusive Content #Opinion #Trends & Analysis

#Drug discovery #Oncology #Organ-on-a-chip

CN Bio service offers support for oncology drug discovery

CN Bio has launched an oncology service which it says is in response to the global need to improve cancer drug discovery approval rates.  Understanding the relationship between pharmacokinetics, pharmacodynamics (PK/PD) and efficacy is critical to the successful development of new medicines, but at present this relationship is primarily investigated using… Read More

#News

#Cell culture #Drug discovery #Organ-on-a-chip

Sitting down with…CN Bio

CN Bio is a cell culture company whose mission is to transform the way human-relevant pre-clinical data is generated by developing the most complete model of the human ‘body-on-a-chip’ in the laboratory.  Achieving this is what drives the company’s future initiatives, CEO Dr David Hughes told Lu Rahman. CN Bio… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Covid-19 #Organ-on-a-chip #Therapeutics

CN Bio and University of Melbourne collaborate on COVID-19 therapies

CN Bio has announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients. Harnessing CN Bio’s organ-on-a-chip technology, the aim of the research is to develop a model capable of recapitulating the fibrosis and tissue remodelling seen in chronic interstitial lung disease, often occurring… Read More

#Editor's Choice #News